Tecvayli monotherapy significantly reduces disease progression and mortality in relapsed or refractory multiple myeloma patients, showing a 71% reduction in progression risk and 40% in mortality risk.
SAN DIEGO -- Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, regardless of their obesity status, a database study involving ...
Bitcoin is up 5.59% for the week, driven by institutional consolidation, cooling U.S. inflation, and anticipation of the Digital Asset Market CLARITY Act. MicroStrategy significantly grew its holdings ...
Hosted on MSN
Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its progression. Subscribe to our newsletter for the latest sci-tech news ...
Canada to allow Chinese EV imports at 6.1% tariff, Carney says Says Canada expects China to lower canola tariff Canada welcomes further Chinese investment Trump expresses support for deal BEIJING, Jan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results